The tariff classification of a forensic-use fentanyl detection device from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated April 15, 2025, you requested a tariff classification ruling on behalf of Defense Diagnostics Inc. DBA Defent. Additional information was provided via email on April 24, 2025 and May 9, 2025. DEFENT ONE is a forensic-use detection device that helps to detect trace amounts of fentanyl in a substance. It is in the form of immunoassay fentanyl detection strips housed in an all-in one unit.
The single-use device features a a pre-loaded immunoassay test strip, an integrated scoop, distilled water, and a plastic outer shell. The test strip consists of a wicking pad, a control line, a test line, nitrocellulose membrane, a conjugate pad, a sample pad, and backing. The control line contains goat anti-mouse antibody. The test line contains recombinant target antigen. An Au-line contains anti-fentanyl antibody.
The line is located on the test strip’s nitrocellulose membrane, specifically in the test line region. This is where the anti-fentanyl antibody conjugated to colloidal gold particles is immobilized. When the sample flows through the strip, the presence of fentanyl is indicated by interaction at this line. In use, the sample (crushed pill/powder ) is placed in the provided bag, shaken to distribute particles, inserted into the device, and shaken to thoroughly mix the test sample with pre-measured water.
The user removes the pin and pushes the base of the device up which releases the water and allows the liquid sample to travel vertically up the immunoassay test strip containing monoclonal antibodies that are specific to fentanyl and its analogs. The labeled antibodies bind to the target and the sample passes over a conjugate zone that contains antibodies labeled with color-changing particles (usually gold nanoparticles).
If fentanyl (or its analogs) are present, they bind to the the free antibodies preventing them from binding at the test line(no test line= positive). If no fentanyl is present, the antibodies bind to the immobilized recombinant antigen, which represents a portion of the fentanyl molecule, at the test line (note the device does not contain any fentanyl molecules).
The applicable subheading for the forensic-use fentanyl detection device will be 3822.19.0030, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[d]iagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits, other than those of heading 3006; certified reference materials: [d]iagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits: [o]ther: [c]ontaining antigens or antisera: [o]ther.” The general rate of duty will be free.
Effective March 4, 2025, pursuant to U.S. Note 2(u) to Subchapter III, Chapter 99, all products of China and Hong Kong as provided by heading 9903.01.24, HTSUS, other than products classifiable under headings 9903.01.21, 9903.01.22, and 9903.01.23, HTSUS, will be subject to an additional 20 percent ad valorem rate of duty. At the time of entry, you must report the applicable Chapter 99 heading, i.e.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N347822).